0001209191-23-037549.txt : 20230615
0001209191-23-037549.hdr.sgml : 20230615
20230615184352
ACCESSION NUMBER: 0001209191-23-037549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Scott Andrew
CENTRAL INDEX KEY: 0001614975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39787
FILM NUMBER: 231018929
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioAtla, Inc.
CENTRAL INDEX KEY: 0001826892
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851922320
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-0708
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001826892
BioAtla, Inc.
BCAB
0001614975
Smith Scott Andrew
C/O BIOATLA, INC. 11085 TORREYANA ROAD
SAN DIEGO
CA
92121
1
0
0
0
0
Stock Option (Right to Buy)
3.55
2023-06-14
4
A
0
50000
0.00
A
2033-06-14
Common Stock
50000
50000
D
Stock Option (Right to Buy)
3.55
2023-06-14
4
A
0
5895
0.00
A
2033-06-14
Common Stock
5895
5895
D
100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.
Fully vested and exercisable.
/s/ Christian Vasquez, as Attorney-in-Fact for Scott A. Smith
2023-06-15